TY - JOUR
T1 - Proceedings of the signature series event of the international society for cellular therapy
T2 - “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017
AU - Ciccocioppo, Rachele
AU - Dos Santos, Claudia C.
AU - Baumgart, Daniel C.
AU - Cangemi, Giuseppina C.
AU - Cardinale, Vincenzo
AU - Ciacci, Carolina
AU - De Coppi, Paolo
AU - Haldar, Debashis
AU - Klersy, Catherine
AU - Nostro, M. Cristina
AU - Ott, Michael
AU - Piemonti, Lorenzo
AU - Tomei, Alice A.
AU - Uygun, Basak
AU - Vetrano, Stefania
AU - Orlando, Giuseppe
PY - 2018/3/1
Y1 - 2018/3/1
N2 - A summary of the First Signature Series Event, “Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases,” held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.
AB - A summary of the First Signature Series Event, “Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases,” held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies.
KW - digestive diseases
KW - immune tolerance
KW - mesenchymal stromal cells
KW - tissue regeneration
UR - http://www.scopus.com/inward/record.url?scp=85041579855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041579855&partnerID=8YFLogxK
U2 - 10.1016/j.jcyt.2017.12.004
DO - 10.1016/j.jcyt.2017.12.004
M3 - Review article
AN - SCOPUS:85041579855
VL - 20
SP - 461
EP - 476
JO - Cytotherapy
JF - Cytotherapy
SN - 1465-3249
IS - 3
ER -